go back

West Virginia rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $489,779 · 10th–90th $338,844–$489,7790%50%10th$489,779Professionalmedian $489,779 · 10th–90th $489,779–$512,8610%50%90th$489,779$500.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$338,844.16 / $489,778.82 / $489,778.82
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $512,861.38
CareSource
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $489,778.82
CareSource
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $489,778.82
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $489,778.82
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$363,078.05 / $512,861.38 / $575,439.94